The Sixth scientific and practical conference with international participation “Clinical trials of medicinal products in Ukraine: new challenges and responses to them” (hereinafter – the Conference) took place on October 08-09, 2020 at the “Mercure Congress Centre”. It was organized by the Ministry of Health of Ukraine, the National Academy of Medical Sciences of Ukraine, the State Expert Center of the Ministry of Health of Ukraine.
For the first time, the format of the Conference provided both physical (at the venue) and online attendance to ensure quarantine measures to prevent the spread of COVID-19.
The Conference program included 1 plenary and 14 section sessions, and on-line workshop for researchers “Good Clinical Practice (GCP). Regulatory framework for clinical trials” conducted on October 9, 2020.
Eighty speakers made 67 oral presentations (including 13 on-line presentations) on various aspects of the organization of clinical trials of medicinal products and protection of safety and rights of their participants.
Please find HERE the presentations permitted for publication.
Leading scientists of research institutes and medical higher education institutions, health managers, doctors of healthcare facilities, members of ethics committees, representatives of domestic and foreign pharmaceutical manufacturers, and employees of contract research organizations from Germany, the Czech Republic, Italy, Switzerland, Ukraine took part in the Conference. The total number of participants in the Conference was 582 (including 458 on-line participants).
According to the results of the Conference, the proposals of the participants were included in the Resolution (152 Кб) (Завантажено: 25.01.2021 08:42:46)adopted by majority of votes (Downloaded: 13.10.2020 07:57:30).
In order to minimize the risks associated with the conclusion of individual contracts between researchers and foreign sponsors/CROs discussed at the Conference, Arzinger law firm, as a permanent legal partner of the Clinical Trials Subcommittee of the European Business Association, has provided «RECOMMENDATIONS on conclusion of contracts in clinical trials (181.5 Кб) (Завантажено: 25.01.2021 08:42:46)».
